EUVIMEDEUVIMED entdecken
Crossref

Preparation and Evaluation of a Novel 99m Tc-Labeled Niraparib Isonitrile Complex as a Potential PARP-1 Imaging Agent

Qianna Wang, Junhong Feng, Yuhao Jiang, Hang Zhou, Qing Ruan, Guangxing Yin, Junbo Zhang iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Qianna Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (Nationa…. Hauptthemen laut MEDLINE: Piperidines, Indazoles, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly ADP-ribose polymerase (PARP) plays an important role in the DNA repair process and has become an attractive target for cancer therapy in recent years. Given that niraparib has good clinical efficacy as a PARP inhibitor, this study aimed to develop radiolabeled niraparib derivatives for tumor imaging to detect PARP expression and improve the accuracy of stratified patient therapy. The niraparib isonitrile derivative (CNPN) was designed, synthesized, and radiolabeled to obtain the [99mTc]Tc-CNPN complex with high radiochemical purity (>95%). It was lipophilic and stable in vitro. In HeLa cell experiments, the uptake of [99mTc]Tc-CNPN was effectively inhibited by the ligand CNPN, indicating the binding affinity for PARP. According to the biodistribution studies of HeLa tumor-bearing mice, [99mTc]Tc-CNPN has moderate tumor uptake and can be effectively inhibited, demonstrating its specificity for targeting PARP. The SPECT imaging results showed that [99mTc]Tc-CNPN had tumor uptake at 2 h postinjection. All of the results of this study indicated that [99mTc]Tc-CNPN is a promising tumor imaging agent that targets PARP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperidinesIndazolesPoly(ADP-ribose) Polymerase InhibitorsAnimalsHumansMiceHeLa CellsTissue DistributionTomography, Emission-Computed, Single-PhotonRadiopharmaceuticalsPoly (ADP-Ribose) Polymerase-1FemaleTechnetiumNitrilesMice, NudeMice, Inbred BALB C

Stichwörter der Autor:innen

99mTcPARPisonitrileniraparibtumor

Substanzen

niraparibPiperidinesIndazolesPoly(ADP-ribose) Polymerase InhibitorsRadiopharmaceuticalsPoly (ADP-Ribose) Polymerase-1TechnetiumNitriles

Autor:innen und Institutionen

  • Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), College of Chemistry, Beijing Norm…
  • Department of Isotopes, China Institute of Atomic Energy, P.O. Box 2108, Beijing 102413, China.
  • Key Laboratory of Beam Technology of the Ministry of Education, College of Nuclear Science and Technology, Beijing Normal University, Beijing 100875, P. R. China.

ORCID-Profile: Junbo Zhang

Förderung

  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Wang, Q., Feng, J., Jiang, Y., Zhou, H., Ruan, Q., Yin, G., & Zhang, J. (2024). Preparation and Evaluation of a Novel 99m Tc-Labeled Niraparib Isonitrile Complex as a Potential PARP-1 Imaging Agent. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00067

Vancouver

Wang Q, Feng J, Jiang Y, Zhou H, Ruan Q, Yin G, et al. Preparation and Evaluation of a Novel 99m Tc-Labeled Niraparib Isonitrile Complex as a Potential PARP-1 Imaging Agent. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00067

BibTeX
@article{Wang2024,
  author = {Wang, Qianna and Feng, Junhong and Jiang, Yuhao and Zhou, Hang and Ruan, Qing and Yin, Guangxing and Zhang, Junbo},
  title = {Preparation and Evaluation of a Novel 99m Tc-Labeled Niraparib Isonitrile Complex as a Potential PARP-1 Imaging Agent},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00067}
}
Kostenlos starten →